Case Study: Llaama achieves reproducible biopharma AI workflows with Akka

Llaama saves over $7 billion annually in biopharma with Akka

Llaama, a European startup, helps biopharma companies create AI-driven treatments. They faced a challenge in enabling full traceability and reproducibility across complex, distributed AI and data science workflows, a critical need for the highly regulated biopharma industry. To solve this, they chose Akka as the foundational technology for their T2R2 solution.

Using Akka, Llaama built a distributed system that provides an immutable audit trail and cryptographically guaranteed data lineage across all environments. This solution from Akka saved Llaama months of DevOps and database administration effort, allowing them to focus on their core business logic. The result is a programmatically guaranteed system that supports compliance, cuts time to market for new drugs, and ensures both workflow and result reproducibility.

Llaama